COCIR Concept on Medical Software

COCIRCOCIR issued an easy-to-use tool to help determine whether software is a medical device or not. Since the revision of the European Medical Device Directive, in force as of 21 March 2010, the definition for medical devices also includes software used for diagnostic and therapeutic purposes. In December 2009, the European Commission decided to develop a European guidance document to clarify which standalone software is a medical device in its own right.

However, European Member States still interpret current regulation inconsistently, which results in unfair competition and different levels of regulatory control affecting patients, users and COCIR's industry members.

The COCIR decision tree together with the explanatory text and examples may help to solve this situation. COCIR has designed this simple tool to determine whether software is to be considered as a medical device in the European regulatory framework. The COCIR decision tree has been developed based on discussions with various stakeholders. It is offered to the European Commission for inclusion in the future European guidance document on Qualification and Classification of Medical Software.

Koen Cobbaert, COCIR Medical Software Task Force Chair stated "With the COCIR decision tree, you can easily find out whether a software application is considered as a medical device and thus must be CE-marked. We are anxiously awaiting European guidance as we see different approaches among regulators."

Nicole Denjoy, COCIR Secretary General, who presented the COCIR tool to the Steering Committee of the Global Harmonisation Task Force (GHTF) in November and said "This decision tree could be a step forward to global convergence of regulation of medical software."

COCIR is freely sharing this concept and is seeking international acceptance. Comments and suggestions on the COCIR decision tree are welcome and can be sent to Olivier Deneve at This email address is being protected from spambots. You need JavaScript enabled to view it..

About COCIR
COCIR is the voice of the European Radiological, Electromedical and Healthcare IT Industry. COCIR is a non-profit trade association, founded in 1959, representing the medical technology industry in Europe. COCIR's members play a driving role in developing the future of healthcare in Europe and worldwide. COCIR moved to Brussels in January 2006, establishing a permanent office in Brussels to better represent industry in its relations with the European institutions. In February 2007, COCIR opened a China Desk in Beijing to strengthen its presence and support for its members in China.

www.cocir.org

Most Popular Now

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

Standing Up for Health Tech and SMEs: Sh…

AS the new chair of the health and social care council at techUK, Shane Tickell talked to Highland Marketing about his determination to support small and innovative companies, by having...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

Experts Propose Specific and Suited Guid…

Current Artificial Intelligence (AI) models for cancer treatment are trained and approved only for specific intended purposes. GMAI models, in contrast, can handle a wide range of medical data including...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...